Ibogaine safety is usually discussed as a single event: the hours on the monitor while the dose works. That framing misses most of the risk. The dangers of ibogaine arrive in a sequence, some of them weeks before anyone takes a capsule and some of them days after the visions end, and each phase calls for different checks. This timeline lays out what should happen before, during and after dosing, and what to ask at each step. If you are starting from scratch, read what is ibogaine first and come back.
One fact belongs at the top. People have died during and after ibogaine treatment, in clinics as well as outside them, and heart rhythm problems are the suspected cause in many of those deaths. No one knows how often it happens, because no registry records every case. Everything below follows from that.
Why does ibogaine safety need a timeline?
Ibogaine is converted in the body to noribogaine, which lingers far longer than ibogaine itself. Both affect the heart's electrical reset, measured on an electrocardiogram as the QT interval. A long QT interval raises the chance of a dangerous rhythm. Because noribogaine stays in the body, the QT interval commonly stays long past the first day, and in reported cases for more than a week.
Other risks run on their own clocks. Drug interactions are decided weeks before dosing. Vomiting and unsteadiness peak in the first day. The fall in opioid tolerance becomes deadly only when someone uses again, which may be a week or a month later. A clinic's ibogaine safety protocols are only as strong as their weakest phase, so it helps to walk through the phases in order.
What has to happen before dosing day?
The pre-treatment phase is where the clinic has the most time to find problems, and where a reader has the most power to ask questions.
Heart screening
A resting 12-lead ECG, read by a physician, establishes a baseline QT interval and looks for existing rhythm problems. Monitored hospital patients have reached dangerous QT intervals, so a normal baseline is a starting point, not a clearance. Ask who reads the ECG and whether a cardiologist is consulted when something looks borderline.
Electrolytes
Low potassium or magnesium makes a long QT interval more dangerous. Ask whether both are checked and corrected before dosing, and again after vomiting. Magnesium is a reasonable precaution, not proven protection; no study has shown it prevents arrhythmia.
Medications
Ibogaine is cleared by a liver enzyme that varies from person to person, which is why some medicines raise its level. Some antidepressants block that enzyme and need weeks to wash out, not days. Stopping an antidepressant has its own risks and is done only with the prescriber who prescribed it; no article, and no clinic intake form, should tell you to stop one on your own.
Alcohol and benzodiazepines
Heavy use of either must be stabilised first, because withdrawal seizures appear in the fatality reports. A clinic that offers to dose someone still drinking heavily, or still taking high-dose benzodiazepines, is skipping a step that those reports describe.
Methadone and buprenorphine
Both complicate timing. Methadone takes days to clear and itself prolongs the QT interval. Buprenorphine is long-acting and binds tightly, and how long it takes to clear depends on its form and dose; a long-acting monthly injection can stay detectable for a year or more. Routine urine screens can miss it, so ask how the clinic confirms it has cleared. Ask how many days before dosing each must stop and what the patient takes in the meantime.
Stopping either one carries its own overdose risk and is done with a prescriber, never alone. Any switch before dosing is done by the treating clinic's physicians, where the treatment takes place; in the United States no prescriber can lawfully write a prescription for morphine, methadone or another Schedule II opioid to treat opioid use disorder, so this cannot be arranged at home. Never bridge with opioids from any other source: those bought outside a pharmacy may contain fentanyl, and tolerance is already falling.
The setting
Mexico has not scheduled ibogaine, so it is unregulated there, not approved. A clinic can hold a health establishment license, and that is not an approval of ibogaine. Ibogaine and 5-MeO-DMT are both Schedule I in the United States.
What are the risks during the dose and the first 48 hours?
Dosing day is the phase everyone pictures, and the one where continuous monitoring earns its place. Heart rate often slows, blood pressure can shift, and the QT interval lengthens over the hours after the dose. Monitoring can catch a dangerous rhythm early enough to treat it; it does not prevent one and can miss one. Ask what equipment is in the room, who is watching it through the night, and what the plan is if a rhythm turns dangerous, including how far away the nearest hospital is.
Vomiting is common. Beyond the misery, it drains potassium and magnesium at the moment the heart can least afford it, which is why rechecking electrolytes after vomiting matters as much as checking them before. Ask whether intravenous fluids and replacement are available on site.
Ataxia follows the dose. The person will need help walking for at least a day, and falls in a bathroom are a real hazard at this stage. Sleep usually does not come for the first night or two. None of these effects is unusual, but each one is a reason a person should not be alone.
One warning about combinations belongs here, because some programs offer 5-MeO-DMT after ibogaine. 5-MeO-DMT must never be combined with MAO inhibitors, including ayahuasca, other harmala preparations and MAOI antidepressants, because that combination can be fatal. An MAOI antidepressant can keep acting after the last dose, so stopping one shortly before does not make 5-MeO-DMT safe, and stopping an antidepressant, an MAOI included, has its own risks and is done only with the prescriber who prescribed it. Tell both that prescriber and the clinic's physician about any MAOI, ayahuasca or harmala preparation. 5-MeO-DMT can briefly raise blood pressure, so high blood pressure and heart disease belong in screening. Human clinical safety evidence for 5-MeO-DMT is still limited and short-term, and no published study establishes a safe interval between ibogaine and 5-MeO-DMT.
What changes in the first week after ibogaine?
This is the phase most often neglected, and the one where discharge timing matters. Because the QT interval can stay long for more than a week, travel after treatment follows a normal ECG, not a set number of days. Ask for a discharge ECG read against the intake tracing, and ask what happens if it is still long on the planned departure day.
Fainting, a racing or irregular heartbeat or a seizure is an emergency at any time, and the risk lasts at least the first week and until an ECG is normal. Until then no new medicine is started, anti-nausea drugs included, without asking a prescriber who knows about the ibogaine whether it affects the QT interval.
For anyone treated for opioid use, this week carries a second danger that has nothing to do with the heart. Opioid tolerance falls after ibogaine treatment, by an amount no one can predict, so a dose used before treatment can be a fatal overdose. Opioids may also act more strongly than expected. Leave with naloxone, make sure the people around you know how to use it, and call emergency services at any sign of overdose. A negative fentanyl test strip does not make a drug safe, and no published ibogaine study has enrolled a fentanyl-using population, so the research says nothing about how that group fares.
Settle before leaving whether and when methadone or buprenorphine restarts, and who would do it. Methadone for addiction normally comes only from a certified program, and it prolongs the QT interval, so the restart is a medical decision rather than an afterthought.
What does ibogaine safety look like in the weeks after?
Once the ECG is normal and the person is home, the risks shift from the heart to behaviour and medication. Cravings can return. The fall in tolerance does not reverse on a schedule anyone can state, so the overdose warning above stands for weeks, not days. Keep naloxone where the household can reach it, and make sure more than one person knows where it is.
Any medication paused before treatment restarts only with its prescriber, on a plan made before discharge. Antidepressants are the common example, and the prescriber should know the dates of treatment and the discharge ECG result. If the person was on methadone, the certified program that dispensed it needs the same information, since the program decides whether and how it resumes.
Support matters here. Integration therapy, a support group or a trusted clinician who knows what happened gives the person somewhere to take the hard days. A clinic that ends contact at the airport has stopped at the phase where its patients are most alone.
Which questions should you ask a clinic for each phase?
The timeline above turns into a short list of questions. A clinic that answers them in plain words, without defensiveness, is showing you how it works.
- Before dosing: Who reads my ECG? Are potassium and magnesium checked before dosing and again after vomiting? How do you confirm buprenorphine has cleared? Which of my medications need weeks rather than days to wash out, and who manages that with my prescriber?
- During: What monitoring is in the room, who watches it overnight, and how far is the nearest hospital? Who helps me walk?
- The first week: Will I have an ECG before I travel, read against my intake tracing? What happens if it is still long? Will I leave with naloxone and a written emergency plan? Who restarts my medication?
- After: Who do I call in week three if something feels wrong, and what does the clinic do when I call?
A clinic's statement that it has never had a death cannot be checked. Clear answers to the questions above are a better measure than any claim.
Ibogaine safety is a sequence, not a moment, and the phases that get the least attention, the weeks before dosing and the week after, are the ones where the most preparation is possible. The Ibogaine Treatment Guide covers each stage in more depth, from screening to aftercare, and the full ibogaine guide is the place to start if you are weighing treatment for yourself or for someone you love.
Related Articles
Ibogaine Therapy Discharge: What to Settle First
Before ibogaine therapy ends, settle the ECG, the ride home, naloxone, medicines and follow-up, because the heart risk outlasts the clinic stay.
SafetyIbogaine for Fentanyl Addiction: Your Doctor's Role
Ibogaine for fentanyl addiction involves your own doctor before and after treatment: what to share, what to ask, and what no prescriber at home can do.
SafetyIbogaine Safety: 8 Claims to Question Before You Book
Ibogaine safety depends on what you can verify, so here are eight common clinic claims and what is actually known about each one.